The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristics.
作者:
主题词
老年人(Aged);血管紧张素转换酶抑制药(Angiotensin-Converting Enzyme Inhibitors);苯咪唑类(Benzimidazoles);苯甲酸盐类(Benzoates);心血管疾病(Cardiovascular Diseases);临床方案(Clinical Protocols);双盲法(Double-Blind Method);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);心室(Heart Ventricles);人类(Humans);磁共振成像(Magnetic Resonance Imaging);男(雄)性(Male);前瞻性研究(Prospective Studies);质量控制(Quality Control);雷米普利(Ramipril);结果可重复性(Reproducibility of Results);回顾性研究(Retrospective Studies);每搏输出量(Stroke Volume);治疗结果(Treatment Outcome);心室功能障碍, 左(Ventricular Dysfunction, Left)
DOI
10.1007/s00392-009-0014-4
PMID
19347385
发布时间
2021-10-20
- 浏览48
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文